share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael

Recursion Pharmaceuticals | 4:持股變動聲明-高管 Secora Michael
美股SEC公告 ·  09/12 18:29

Moomoo AI 已提取核心訊息

Recursion Pharmaceuticals' Chief Financial Officer, Secora Michael, completed a series of stock transactions on September 10 and 11, 2024. The transactions involved the sale of 30,000 shares of Class A Common Stock at prices ranging from $6.1666 to $6.3153 per share, resulting in a total market value of $187,228.50. Additionally, Secora exercised options to acquire 78,750 shares at a price of $2.22 per share. Following these transactions, Secora Michael holds a total of 1,402,131 shares in the company.
Recursion Pharmaceuticals' Chief Financial Officer, Secora Michael, completed a series of stock transactions on September 10 and 11, 2024. The transactions involved the sale of 30,000 shares of Class A Common Stock at prices ranging from $6.1666 to $6.3153 per share, resulting in a total market value of $187,228.50. Additionally, Secora exercised options to acquire 78,750 shares at a price of $2.22 per share. Following these transactions, Secora Michael holds a total of 1,402,131 shares in the company.
Recursion Pharmaceuticals的致富金融(臨時代碼)官員Secora Michael在2024年9月10日和11日完成了一系列股票交易。 這些交易涉及以每股6.1666美元至6.3153美元的價格出售30,000股A類普通股,導致總市值爲187,228.50美元。此外,Secora行使了期權,以每股2.22美元的價格獲得78,750股股票。在這些交易後,Secora Michael在該公司持有總共1,402,131股。
Recursion Pharmaceuticals的致富金融(臨時代碼)官員Secora Michael在2024年9月10日和11日完成了一系列股票交易。 這些交易涉及以每股6.1666美元至6.3153美元的價格出售30,000股A類普通股,導致總市值爲187,228.50美元。此外,Secora行使了期權,以每股2.22美元的價格獲得78,750股股票。在這些交易後,Secora Michael在該公司持有總共1,402,131股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息